Stegostoma fasciatum isolate 6-17 chromosome 31, sSteFas1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Stegostomatidae; Stegostoma.
REFSEQ INFORMATION: The reference sequence is identical to\nCM039257.1.\nAssembly name: sSteFas1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Squalomix on 2022/02/17. The\noriginal whole-genome shotgun project has the accession\nJAFIRC000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Squalomix\nAssembly Date :: 22-FEB-2021\nAssembly Method :: Platanus v. 1.2.4; P_RNA_scaffolder v.\n commit 7941e0f on May 30, at github;\n 3D-DNA v. 180922\nAssembly Name :: sSteFas1.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 95.8x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Stegostoma fasciatum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
UBX domain protein 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
UBX domain protein 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
von Willebrand factor A domain containing 5B1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
von Willebrand factor A domain containing 5B1, transcript variant X3
von Willebrand factor A domain containing 5B1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
von Willebrand factor A domain containing 5B1, transcript variant X2
von Willebrand factor A domain-containing protein 5B1 isoform X1
von Willebrand factor A domain-containing protein 5B1 isoform X2
von Willebrand factor A domain-containing protein 5B1 isoform X3
calcium/calmodulin-dependent protein kinase II inhibitor 1b
mitochondrial E3 ubiquitin protein ligase 1b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
mitochondrial ubiquitin ligase activator of NFKB 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor
transcription initiation factor TFIID subunit 10
peptidylprolyl isomerase H (cyclophilin H)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
polyhomeotic-like protein 2, transcript variant X2
polyhomeotic-like protein 2, transcript variant X3
polyhomeotic-like protein 2, transcript variant X8
polyhomeotic-like protein 2, transcript variant X1
polyhomeotic-like protein 2, transcript variant X5
polyhomeotic-like protein 2, transcript variant X6
polyhomeotic-like protein 2, transcript variant X7
polyhomeotic-like protein 2, transcript variant X9
polyhomeotic-like protein 2, transcript variant X10
polyhomeotic-like protein 2, transcript variant X4
polyhomeotic-like protein 2, transcript variant X12
polyhomeotic-like protein 2, transcript variant X11
polyhomeotic-like protein 2, transcript variant X13
polyhomeotic-like protein 2, transcript variant X14
polyhomeotic-like protein 2, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat-containing protein 47
small integral membrane protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
small integral membrane protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
small integral membrane protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
coiled-coil domain-containing protein 27-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit delta isoform X2
gamma-aminobutyric acid receptor subunit delta isoform X1
cilia and flagella associated protein 74, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cilia and flagella associated protein 74, transcript variant X2
cilia and flagella associated protein 74, transcript variant X3
cilia- and flagella-associated protein 74 isoform X1
cilia- and flagella-associated protein 74 isoform X2
cilia- and flagella-associated protein 74 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 35 member E2A, transcript variant X1
solute carrier family 35 member E2A, transcript variant X3
solute carrier family 35 member E2A, transcript variant X2
solute carrier family 35 member E2A, transcript variant X4
cyclin-dependent kinase 11B, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X6
cyclin-dependent kinase 11B, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cyclin-dependent kinase 11B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
matrix metallopeptidase 23ba, transcript variant X2
matrix metallopeptidase 23ba, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, transcript variant X4
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, transcript variant X1
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, transcript variant X2
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, transcript variant X5
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, transcript variant X6
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, transcript variant X3
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
MIB E3 ubiquitin protein ligase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MIB E3 ubiquitin protein ligase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
MIB E3 ubiquitin protein ligase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MIB E3 ubiquitin protein ligase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
E3 ubiquitin-protein ligase MIB2 isoform X1
E3 ubiquitin-protein ligase MIB2 isoform X2
MIB E3 ubiquitin protein ligase 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
E3 ubiquitin-protein ligase MIB2 isoform X3
MIB E3 ubiquitin protein ligase 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
E3 ubiquitin-protein ligase MIB2 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 5-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 5-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 5-like, transcript variant X12
tumor necrosis factor receptor superfamily member 5-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 5-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 5-like, transcript variant X4
tumor necrosis factor receptor superfamily member 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 5-like, transcript variant X2
tumor necrosis factor receptor superfamily member 5-like, transcript variant X7
tumor necrosis factor receptor superfamily member 5-like isoform X6
tumor necrosis factor receptor superfamily member 5-like isoform X5
tumor necrosis factor receptor superfamily member 5-like isoform X2
tumor necrosis factor receptor superfamily member 5-like isoform X1
tumor necrosis factor receptor superfamily member 5-like, transcript variant X10
tumor necrosis factor receptor superfamily member 5-like, transcript variant X9
tumor necrosis factor receptor superfamily member 5-like isoform X4
tumor necrosis factor receptor superfamily member 5-like isoform X3
uncharacterized LOC125466669, transcript variant X2
uncharacterized LOC125466669, transcript variant X1
castor zinc finger 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
castor zinc finger 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
castor zinc finger 1, transcript variant X3
castor zinc finger 1, transcript variant X4
castor zinc finger 1, transcript variant X5
castor zinc finger 1, transcript variant X2
castor zinc finger 1, transcript variant X7
castor zinc finger 1, transcript variant X8
zinc finger protein castor homolog 1 isoform X1
zinc finger protein castor homolog 1 isoform X5
zinc finger protein castor homolog 1 isoform X2
zinc finger protein castor homolog 1 isoform X3
zinc finger protein castor homolog 1 isoform X4
zinc finger protein castor homolog 1 isoform X7
zinc finger protein castor homolog 1 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
DNA fragmentation factor, alpha polypeptide, transcript variant X2
DNA fragmentation factor, alpha polypeptide, transcript variant X1
centromere protein S, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
centromere protein S, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 6B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
6-phosphogluconate dehydrogenase, decarboxylating
kinesin family member 1B, transcript variant X16
kinesin family member 1B, transcript variant X2
kinesin family member 1B, transcript variant X23
kinesin family member 1B, transcript variant X17
kinesin family member 1B, transcript variant X15
kinesin family member 1B, transcript variant X21
kinesin family member 1B, transcript variant X9
kinesin family member 1B, transcript variant X5
kinesin family member 1B, transcript variant X22
kinesin family member 1B, transcript variant X14
kinesin family member 1B, transcript variant X13
kinesin family member 1B, transcript variant X4
kinesin family member 1B, transcript variant X12
kinesin family member 1B, transcript variant X11
kinesin family member 1B, transcript variant X20
kinesin family member 1B, transcript variant X6
kinesin family member 1B, transcript variant X10
kinesin family member 1B, transcript variant X8
kinesin family member 1B, transcript variant X7
kinesin family member 1B, transcript variant X3
kinesin family member 1B, transcript variant X1
kinesin family member 1B, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
kinesin family member 1B, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
kinesin family member 1B, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ubiquitination factor E4B, UFD2 homolog (S. cerevisiae), transcript variant X1
ubiquitination factor E4B, UFD2 homolog (S. cerevisiae), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ubiquitin conjugation factor E4 B isoform X2
ubiquitin conjugation factor E4 B isoform X1
nicotinamide nucleotide adenylyltransferase 1
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1
uncharacterized LOC125466697, transcript variant X3
uncharacterized LOC125466697, transcript variant X1
uncharacterized LOC125466697, transcript variant X4
uncharacterized LOC125466697, transcript variant X2
uncharacterized LOC125466697, transcript variant X5
uncharacterized protein LOC125466697 isoform X1
uncharacterized protein LOC125466697 isoform X2
uncharacterized protein LOC125466697 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
leucine zipper and CTNNBIP1 domain containing
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, transcript variant X6
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, transcript variant X5
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, transcript variant X1
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, transcript variant X2
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, transcript variant X8
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, transcript variant X9
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 201, transcript variant X1
transmembrane protein 201, transcript variant X2
transmembrane protein 201, transcript variant X3
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X1
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X2
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X4
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X5
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X3
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X6
SPRY domain-containing SOCS box protein 1
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase), transcript variant X1
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
GDH/6PGL endoplasmic bifunctional protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 1a
carbonic anhydrase VI, transcript variant X3
carbonic anhydrase VI, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
carbonic anhydrase VI, transcript variant X1
enolase 1a, (alpha), transcript variant X6
enolase 1a, (alpha), transcript variant X4
enolase 1a, (alpha), transcript variant X2
enolase 1a, (alpha), transcript variant X1
enolase 1a, (alpha), transcript variant X5
enolase 1a, (alpha), transcript variant X3
enolase 1a, (alpha), transcript variant X7
arginine-glutamic acid dipeptide (RE) repeats a, transcript variant X1
arginine-glutamic acid dipeptide (RE) repeats a, transcript variant X5
arginine-glutamic acid dipeptide (RE) repeats a, transcript variant X6
arginine-glutamic acid dipeptide (RE) repeats a, transcript variant X7
arginine-glutamic acid dipeptide (RE) repeats a, transcript variant X3
arginine-glutamic acid dipeptide (RE) repeats a, transcript variant X2
arginine-glutamic acid dipeptide (RE) repeats a, transcript variant X4
arginine-glutamic acid dipeptide repeats protein isoform X1
arginine-glutamic acid dipeptide repeats protein isoform X2
arginine-glutamic acid dipeptide repeats protein isoform X3
arginine-glutamic acid dipeptide repeats protein isoform X4
arginine-glutamic acid dipeptide (RE) repeats a, transcript variant X8
arginine-glutamic acid dipeptide repeats protein isoform X5
arginine-glutamic acid dipeptide (RE) repeats a, transcript variant X9
arginine-glutamic acid dipeptide repeats protein isoform X6
sterile alpha motif domain containing 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sterile alpha motif domain containing 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sterile alpha motif domain containing 11, transcript variant X1
sterile alpha motif domain containing 11, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sterile alpha motif domain containing 11, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
sterile alpha motif domain containing 11, transcript variant X5
sterile alpha motif domain-containing protein 11 isoform X2
sterile alpha motif domain-containing protein 11 isoform X3
sterile alpha motif domain-containing protein 11 isoform X1
sterile alpha motif domain-containing protein 11 isoform X6
sterile alpha motif domain-containing protein 11 isoform X4
sterile alpha motif domain-containing protein 11 isoform X5
NOC2-like nucleolar associated transcriptional repressor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
kelch-like family member 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
kelch-like family member 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kelch-like family member 17, transcript variant X3
kelch-like family member 17, transcript variant X4
pleckstrin homology domain containing, family N member 1, transcript variant X1
pleckstrin homology domain containing, family N member 1, transcript variant X2
pleckstrin homology domain containing, family N member 1, transcript variant X4
pleckstrin homology domain containing, family N member 1, transcript variant X5
pleckstrin homology domain containing, family N member 1, transcript variant X3
probable pleckstrin homology domain-containing family N member 1 isoform X1
probable pleckstrin homology domain-containing family N member 1 isoform X2
probable pleckstrin homology domain-containing family N member 1 isoform X4
probable pleckstrin homology domain-containing family N member 1 isoform X5
probable pleckstrin homology domain-containing family N member 1 isoform X3
PPARGC1 and ESRR induced regulator, muscle 1
PGC-1 and ERR-induced regulator in muscle protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 11b, transcript variant X2
protein tyrosine phosphatase non-receptor type 11b, transcript variant X1
protein tyrosine phosphatase non-receptor type 11b, transcript variant X3
tyrosine-protein phosphatase non-receptor type 11b isoform X2
tyrosine-protein phosphatase non-receptor type 11b isoform X1
chromosome 31 C1orf159 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
chromosome 31 C1orf159 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
chromosome 31 C1orf159 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
chromosome 31 C1orf159 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein C1orf159 homolog isoform X2
uncharacterized protein C1orf159 homolog isoform X3
uncharacterized protein C1orf159 homolog isoform X4
uncharacterized protein C1orf159 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
probable pleckstrin homology domain-containing family N member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 4-like, transcript variant X3
tumor necrosis factor receptor superfamily member 4-like, transcript variant X1
tumor necrosis factor receptor superfamily member 4-like, transcript variant X2
tumor necrosis factor receptor superfamily member 4-like isoform X3
tumor necrosis factor receptor superfamily member 4-like isoform X1
tumor necrosis factor receptor superfamily member 4-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
hes family bHLH transcription factor 2, tandem duplicate 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
acyl-CoA thioesterase 7, transcript variant X1
acyl-CoA thioesterase 7, transcript variant X2
cytosolic acyl coenzyme A thioester hydrolase isoform X1
cytosolic acyl coenzyme A thioester hydrolase isoform X2
acyl-CoA thioesterase 7, transcript variant X4
acyl-CoA thioesterase 7, transcript variant X5
acyl-CoA thioesterase 7, transcript variant X3
cytosolic acyl coenzyme A thioester hydrolase isoform X3
cytosolic acyl coenzyme A thioester hydrolase isoform X4
probable G-protein coupled receptor 153, transcript variant X7
probable G-protein coupled receptor 153, transcript variant X5
probable G-protein coupled receptor 153, transcript variant X1
probable G-protein coupled receptor 153, transcript variant X2
probable G-protein coupled receptor 153, transcript variant X6
probable G-protein coupled receptor 153, transcript variant X3
probable G-protein coupled receptor 153, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: prostamide/prostaglandin F synthase
membrane metallo-endopeptidase-like 1, transcript variant X2
membrane metallo-endopeptidase-like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
membrane metallo-endopeptidase-like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
membrane metallo-endopeptidase-like 1 isoform X2
membrane metallo-endopeptidase-like 1 isoform X1
membrane metallo-endopeptidase-like 1 isoform X3
tetratricopeptide repeat domain 34, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
tetratricopeptide repeat domain 34, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 363 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 801 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 913 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 108 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125466489, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC125466489, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC125466489, transcript variant X2
uncharacterized LOC125466489, transcript variant X1
uncharacterized LOC125466489, transcript variant X3
PR domain containing 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
PR domain containing 16, transcript variant X2
histone-lysine N-methyltransferase PRDM16 isoform X1
histone-lysine N-methyltransferase PRDM16 isoform X2
Rho guanine nucleotide exchange factor (GEF) 16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
rho guanine nucleotide exchange factor 16
multiple epidermal growth factor-like domains protein 6, transcript variant X1
multiple epidermal growth factor-like domains protein 6, transcript variant X2
multiple epidermal growth factor-like domains protein 6, transcript variant X3
multiple epidermal growth factor-like domains protein 6, transcript variant X4
multiple epidermal growth factor-like domains protein 6 isoform X2
multiple epidermal growth factor-like domains protein 6 isoform X1
multiple epidermal growth factor-like domains protein 6 isoform X3
multiple epidermal growth factor-like domains protein 6 isoform X4
tumor protein p63-regulated gene 1-like protein
WD repeat containing, antisense to TP73, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
WD repeat-containing protein WRAP73 isoform X1
WD repeat containing, antisense to TP73, transcript variant X2
WD repeat-containing protein WRAP73 isoform X2
tumor protein p73, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor protein p73, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor protein p73, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor protein p73, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
tumor protein p73, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
protein kinase C zeta type, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein kinase C zeta type, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein kinase C zeta type, transcript variant X2
protein kinase C zeta type, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein kinase C zeta type, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein kinase C zeta type, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein kinase C zeta type, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein kinase C zeta type, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein kinase C zeta type, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein kinase C zeta type, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
v-ski avian sarcoma viral oncogene homolog a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
retention in endoplasmic reticulum sorting receptor 1, transcript variant X1
retention in endoplasmic reticulum sorting receptor 1, transcript variant X3
retention in endoplasmic reticulum sorting receptor 1, transcript variant X2
peroxisomal biogenesis factor 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
peroxisomal biogenesis factor 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
peroxisomal biogenesis factor 10, transcript variant X2
phospholipase C, eta 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2a isoform X1
phospholipase C, eta 2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipase C, eta 2a, transcript variant X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2a isoform X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2a isoform X3
probable glutamate receptor, transcript variant X2
probable glutamate receptor, transcript variant X1
pantothenate kinase 4 (inactive), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
pantothenate kinase 4 (inactive), transcript variant X1
4'-phosphopantetheine phosphatase isoform X2
4'-phosphopantetheine phosphatase isoform X1
vesicle-associated membrane protein 3-like
calmodulin-binding transcription activator 1-like, transcript variant X7
calmodulin-binding transcription activator 1-like, transcript variant X6
calmodulin-binding transcription activator 1-like, transcript variant X3
calmodulin-binding transcription activator 1-like, transcript variant X5
calmodulin-binding transcription activator 1-like, transcript variant X2
calmodulin-binding transcription activator 1-like, transcript variant X4
calmodulin-binding transcription activator 1-like, transcript variant X1
calmodulin-binding transcription activator 1-like, transcript variant X8
calmodulin-binding transcription activator 1-like isoform X5
calmodulin-binding transcription activator 1-like isoform X2
calmodulin-binding transcription activator 1-like isoform X6
calmodulin-binding transcription activator 1-like isoform X3
calmodulin-binding transcription activator 1-like isoform X4
calmodulin-binding transcription activator 1-like isoform X1
calmodulin-binding transcription activator 1-like isoform X7
calmodulin-binding transcription activator 1-like isoform X8
THAP domain containing, apoptosis associated protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
THAP domain containing, apoptosis associated protein 3, transcript variant X2
THAP domain-containing protein 3 isoform X1
THAP domain-containing protein 3 isoform X2
kelch-like family member 21, transcript variant X1
kelch-like family member 21, transcript variant X2
zinc finger and BTB domain containing 48, transcript variant X7
zinc finger and BTB domain containing 48, transcript variant X6
zinc finger and BTB domain containing 48, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
zinc finger and BTB domain containing 48, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger and BTB domain containing 48, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger and BTB domain containing 48, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger and BTB domain containing 48, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
telomere zinc finger-associated protein isoform X3
telomere zinc finger-associated protein isoform X2
telomere zinc finger-associated protein isoform X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ribosomal protein L22, transcript variant X3
ribosomal protein L22, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
ribosomal protein L22, transcript variant X2
chromodomain helicase DNA binding protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
chromodomain helicase DNA binding protein 5, transcript variant X2
chromodomain-helicase-DNA-binding protein 5
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X8
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X3
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X7
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X9
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X4
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X6
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X11
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X12
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X13
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X5
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X10
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X14
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X1
potassium voltage-gated channel subfamily A regulatory beta subunit 2a, transcript variant X2
voltage-gated potassium channel subunit beta-2 isoform X6
voltage-gated potassium channel subunit beta-2 isoform X4
voltage-gated potassium channel subunit beta-2 isoform X5
voltage-gated potassium channel subunit beta-2 isoform X3
voltage-gated potassium channel subunit beta-2 isoform X2
voltage-gated potassium channel subunit beta-2 isoform X1
voltage-gated potassium channel subunit beta-2 isoform X7
tumor necrosis factor receptor superfamily member 9-like, transcript variant X3
tumor necrosis factor receptor superfamily member 9-like, transcript variant X6
tumor necrosis factor receptor superfamily member 9-like, transcript variant X4
tumor necrosis factor receptor superfamily member 9-like, transcript variant X5
tumor necrosis factor receptor superfamily member 9-like, transcript variant X1
tumor necrosis factor receptor superfamily member 9-like isoform X1
tumor necrosis factor receptor superfamily member 9-like, transcript variant X7
tumor necrosis factor receptor superfamily member 9-like, transcript variant X2
tumor necrosis factor receptor superfamily member 9-like isoform X2
tumor necrosis factor receptor superfamily member 9-like isoform X3
coiled-coil domain-containing protein 50-like, transcript variant X2
coiled-coil domain-containing protein 50-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
coiled-coil domain-containing protein 50-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
coiled-coil domain-containing protein 50-like isoform X1
coiled-coil domain-containing protein 50-like isoform X2
coiled-coil domain-containing protein 50-like isoform X3
paired box protein Pax-7, transcript variant X2
paired box protein Pax-7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
paired box protein Pax-7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
paired box protein Pax-7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
paired box protein Pax-7, transcript variant X5
sphingosine-1-phosphate phosphatase 2-like, transcript variant X1
sphingosine-1-phosphate phosphatase 2-like, transcript variant X2
sphingosine-1-phosphate phosphatase 2-like isoform X1
sphingosine-1-phosphate phosphatase 2-like isoform X2
mitochondrial ribosomal protein S16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
mitochondrial ribosomal protein S16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
28S ribosomal protein S16, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
outer dynein arm docking complex subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
outer dynein arm docking complex subunit 1, transcript variant X2
coiled-coil domain-containing protein 114 isoform X1
coiled-coil domain-containing protein 114 isoform X2
uncharacterized protein LOC556929 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC556929 homolog, transcript variant X1
uncharacterized protein zgc:154075 isoform X3
uncharacterized protein zgc:154075 isoform X1
uncharacterized protein LOC556929 homolog, transcript variant X2
uncharacterized protein zgc:154075 isoform X2
uncharacterized protein LOC556929 homolog, transcript variant X4
putative 4,5-dihydroxyphthalate dehydrogenase isoform X4
solute carrier family 45 member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 45 member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 45 member 1, transcript variant X2
solute carrier family 45 member 1, transcript variant X5
solute carrier family 45 member 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 45 member 1, transcript variant X4
proton-associated sugar transporter A isoform X1
proton-associated sugar transporter A isoform X2
ERBB receptor feedback inhibitor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ERBB receptor feedback inhibitor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
segment polarity protein dishevelled homolog DVL-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
segment polarity protein dishevelled homolog DVL-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
segment polarity protein dishevelled homolog DVL-1-like isoform X1
segment polarity protein dishevelled homolog DVL-1-like isoform X2
matrix remodeling-associated protein 8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
matrix remodeling-associated protein 8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
matrix remodeling-associated protein 8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
matrix remodeling-associated protein 8-like isoform X2
matrix remodeling-associated protein 8-like isoform X3
matrix remodeling-associated protein 8-like isoform X1
zona pellucida-binding protein 1-like, transcript variant X2
zona pellucida-binding protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
zona pellucida-binding protein 1-like isoform X1
zona pellucida-binding protein 1-like isoform X2
nucleolar protein 9, transcript variant X1
nucleolar protein 9, transcript variant X5
nucleolar protein 9, transcript variant X2
nucleolar protein 9, transcript variant X3
nucleolar protein 9, transcript variant X4
polynucleotide 5'-hydroxyl-kinase NOL9 isoform X1
polynucleotide 5'-hydroxyl-kinase NOL9 isoform X2
pleckstrin homology domain containing, family G (with RhoGef domain) member 5a, transcript variant X1
pleckstrin homology domain-containing family G member 5 isoform X1
pleckstrin homology domain containing, family G (with RhoGef domain) member 5a, transcript variant X7
pleckstrin homology domain containing, family G (with RhoGef domain) member 5a, transcript variant X2
pleckstrin homology domain containing, family G (with RhoGef domain) member 5a, transcript variant X5
pleckstrin homology domain-containing family G member 5 isoform X2
pleckstrin homology domain containing, family G (with RhoGef domain) member 5a, transcript variant X3
pleckstrin homology domain-containing family G member 5 isoform X3
pleckstrin homology domain containing, family G (with RhoGef domain) member 5a, transcript variant X4
pleckstrin homology domain-containing family G member 5 isoform X4
pleckstrin homology domain-containing family G member 5 isoform X5
pleckstrin homology domain containing, family G (with RhoGef domain) member 5a, transcript variant X6
pleckstrin homology domain-containing family G member 5 isoform X6
tumor necrosis factor receptor superfamily member 25-like
tumor necrosis factor receptor superfamily member 1B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 1B-like, transcript variant X2
tumor necrosis factor receptor superfamily member 1B-like, transcript variant X1
tumor necrosis factor receptor superfamily member 1B-like, transcript variant X4
tumor necrosis factor receptor superfamily member 1B-like isoform X3
tumor necrosis factor receptor superfamily member 1B-like isoform X2
tumor necrosis factor receptor superfamily member 1B-like isoform X1
tumor necrosis factor receptor superfamily member 1B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
migration and invasion inhibitory protein, transcript variant X4
migration and invasion inhibitory protein, transcript variant X3
migration and invasion inhibitory protein, transcript variant X2
migration and invasion inhibitory protein, transcript variant X1
uncharacterized protein LOC125466499 isoform X2
uncharacterized protein LOC125466499 isoform X1
uncharacterized protein LOC125466499 isoform X3
migration and invasion inhibitory protein, transcript variant X5
uncharacterized protein LOC125466499 isoform X4
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1a, transcript variant X1
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1a, transcript variant X2
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1a, transcript variant X3
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 isoform X2
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 isoform X3
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized protein KIAA2013 homolog
C-type natriuretic peptide prohormone-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
methylenetetrahydrofolate reductase (NAD(P)H), transcript variant X2
methylenetetrahydrofolate reductase (NAD(P)H), transcript variant X1
angiotensin II receptor-associated protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
angiotensin II receptor-associated protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
angiotensin II receptor-associated protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
type-1 angiotensin II receptor-associated protein isoform X1
type-1 angiotensin II receptor-associated protein isoform X2
type-1 angiotensin II receptor-associated protein isoform X3
mitotic spindle assembly checkpoint protein MAD2B
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase), transcript variant X1
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase), transcript variant X2
aflatoxin B1 aldehyde reductase member 3 isoform X1
aflatoxin B1 aldehyde reductase member 3 isoform X2
MRT4 homolog, ribosome maturation factor, transcript variant X2
MRT4 homolog, ribosome maturation factor, transcript variant X1
mRNA turnover protein 4 homolog isoform X1
mRNA turnover protein 4 homolog isoform X2
ER membrane protein complex subunit 1, transcript variant X1
ER membrane protein complex subunit 1, transcript variant X2
ER membrane protein complex subunit 1 isoform X1
ER membrane protein complex subunit 1 isoform X2
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X1
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X3
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X2
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X5
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X7
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
E3 ubiquitin-protein ligase UBR4 isoform X1
E3 ubiquitin-protein ligase UBR4 isoform X3
E3 ubiquitin-protein ligase UBR4 isoform X4
E3 ubiquitin-protein ligase UBR4 isoform X2
E3 ubiquitin-protein ligase UBR4 isoform X6
E3 ubiquitin-protein ligase UBR4 isoform X5
E3 ubiquitin-protein ligase UBR4 isoform X8
E3 ubiquitin-protein ligase UBR4 isoform X7
E3 ubiquitin-protein ligase UBR4 isoform X9
E3 ubiquitin-protein ligase UBR4 isoform X10
intermediate filament family orphan 2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: intermediate filament family orphan 2-like
uncharacterized LOC125466487, transcript variant X2
uncharacterized LOC125466487, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial-like
aurora kinase A interacting protein 1, transcript variant X2
aurora kinase A interacting protein 1, transcript variant X1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3a, transcript variant X2
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3a, transcript variant X1
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X2
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X1
pseudouridine synthase like 1, transcript variant X3
pseudouridine synthase like 1, transcript variant X1
pseudouridine synthase like 1, transcript variant X4
pseudouridine synthase like 1, transcript variant X2
tRNA pseudouridine synthase-like 1 isoform X1
tRNA pseudouridine synthase-like 1 isoform X4
tRNA pseudouridine synthase-like 1 isoform X2
tRNA pseudouridine synthase-like 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
integrator complex subunit 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
integrator complex subunit 11, transcript variant X1
integrator complex subunit 11 isoform X1
integrator complex subunit 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
integrator complex subunit 11 isoform X2
zinc finger protein 239-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
zinc finger protein 239-like, transcript variant X1
zinc finger protein 239-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
stromal cell derived factor 4, transcript variant X2
stromal cell derived factor 4, transcript variant X1
UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
C1q and TNF related 12, transcript variant X2
C1q and TNF related 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
C1q and TNF related 12, transcript variant X4
C1q and TNF related 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
lactamase, beta-like 1b, transcript variant X2
lactamase, beta-like 1b, transcript variant X3
lactamase, beta-like 1b, transcript variant X1
ubiquitin-conjugating enzyme E2, J2 (UBC6 homolog, yeast), transcript variant X1
ubiquitin-conjugating enzyme E2, J2 (UBC6 homolog, yeast), transcript variant X2
ubiquitin-conjugating enzyme E2, J2 (UBC6 homolog, yeast), transcript variant X4
ubiquitin-conjugating enzyme E2, J2 (UBC6 homolog, yeast), transcript variant X3
39S ribosomal protein L20, mitochondrial
ankyrin repeat domain-containing protein 65-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
von Willebrand factor A domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
von Willebrand factor A domain-containing protein 1
uncharacterized LOC125466743, transcript variant X2
uncharacterized LOC125466743, transcript variant X1
uncharacterized protein LOC125466743 isoform X1
uncharacterized protein LOC125466743 isoform X2
SSU72 homolog, RNA polymerase II CTD phosphatase
RNA polymerase II subunit A C-terminal domain phosphatase SSU72
fibronectin type III domain containing 10
fibronectin type III domain-containing protein 10
Golgi integral membrane protein 4-like, transcript variant X3
Golgi integral membrane protein 4-like, transcript variant X2
Golgi integral membrane protein 4-like, transcript variant X1
Golgi integral membrane protein 4-like isoform X3
Golgi integral membrane protein 4-like isoform X2
Golgi integral membrane protein 4-like isoform X1
olfactory receptor class A-like protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
OTU deubiquitinase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
OTU deubiquitinase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
transmembrane and coiled-coil domains 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transmembrane and coiled-coil domains 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
transmembrane and coiled-coil domains 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane and coiled-coil domain-containing protein 4 isoform X1
transmembrane and coiled-coil domain-containing protein 4 isoform X2
5-hydroxytryptamine (serotonin) receptor 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
NBL1, DAN family BMP antagonist, transcript variant X3
NBL1, DAN family BMP antagonist, transcript variant X1
NBL1, DAN family BMP antagonist, transcript variant X2
neuroblastoma suppressor of tumorigenicity 1
mitochondrial contact site and cristae organizing system subunit 10, transcript variant X1
mitochondrial contact site and cristae organizing system subunit 10, transcript variant X2
capping actin protein of muscle Z-line subunit beta, transcript variant X2
capping actin protein of muscle Z-line subunit beta, transcript variant X1
F-actin-capping protein subunit beta isoform X1
F-actin-capping protein subunit beta isoform X2
solute carrier family 66 member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 66 member 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 66 member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
solute carrier family 66 member 1, transcript variant X1
solute carrier family 66 member 1, transcript variant X3
lysosomal amino acid transporter 1 homolog isoform X2
lysosomal amino acid transporter 1 homolog isoform X1
PTEN induced kinase 1, transcript variant X2
PTEN induced kinase 1, transcript variant X1
serine/threonine-protein kinase PINK1, mitochondrial isoform X1
serine/threonine-protein kinase PINK1, mitochondrial isoform X2
PTEN induced kinase 1, transcript variant X3
serine/threonine-protein kinase PINK1, mitochondrial isoform X3
agmatine ureohydrolase (agmatinase), transcript variant X2
agmatine ureohydrolase (agmatinase), transcript variant X1
DnaJ (Hsp40) homolog, subfamily C, member 16, transcript variant X2
DnaJ (Hsp40) homolog, subfamily C, member 16, transcript variant X1
DnaJ (Hsp40) homolog, subfamily C, member 16, transcript variant X3
dnaJ homolog subfamily C member 16 isoform X2
dnaJ homolog subfamily C member 16 isoform X1
dnaJ homolog subfamily C member 16 isoform X3
caspase 9, apoptosis-related cysteine peptidase, transcript variant X1
caspase 9, apoptosis-related cysteine peptidase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
caspase 9, apoptosis-related cysteine peptidase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic)
dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit
DNA-damage inducible protein 2, transcript variant X1
DNA-damage inducible protein 2, transcript variant X3
DNA-damage inducible protein 2, transcript variant X4
DNA-damage inducible protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Rho guanine nucleotide exchange factor (GEF) 19, transcript variant X1
Rho guanine nucleotide exchange factor (GEF) 19, transcript variant X2
Rho guanine nucleotide exchange factor (GEF) 19, transcript variant X3
rho guanine nucleotide exchange factor 19 isoform X1
rho guanine nucleotide exchange factor 19 isoform X2
rho guanine nucleotide exchange factor 19 isoform X3
family with sequence similarity 131 member C, transcript variant X2
family with sequence similarity 131 member C, transcript variant X1
chloride channel K, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chloride channel K, transcript variant X2
chloride channel K, transcript variant X6
chloride channel K, transcript variant X4
chloride channel K, transcript variant X5
chloride channel K, transcript variant X3
heat shock protein family, member 7 (cardiovascular)
pleckstrin homology domain containing, family M (with RUN domain) member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pleckstrin homology domain containing, family M (with RUN domain) member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
pleckstrin homology domain containing, family M (with RUN domain) member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
pleckstrin homology domain-containing family M member 2 isoform X1
pleckstrin homology domain-containing family M member 2 isoform X2
pleckstrin homology domain-containing family M member 2 isoform X3
solute carrier family 25 member 35-like, transcript variant X1
solute carrier family 25 member 35-like, transcript variant X2
solute carrier family 25 member 35-like isoform X1
solute carrier family 25 member 35-like isoform X2
spen family transcriptional repressor, transcript variant X1
spen family transcriptional repressor, transcript variant X4
spen family transcriptional repressor, transcript variant X3
spen family transcriptional repressor, transcript variant X2
spen family transcriptional repressor, transcript variant X5
zinc finger and BTB domain containing 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger and BTB domain containing 17, transcript variant X1
zinc finger and BTB domain-containing protein 17 isoform X2
zinc finger and BTB domain-containing protein 17 isoform X1
adaptin ear-binding coat-associated protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ATPase cation transporting 13A2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ATPase cation transporting 13A2, transcript variant X6
ATPase cation transporting 13A2, transcript variant X7
cation-transporting ATPase 13A2 isoform X4
ATPase cation transporting 13A2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ATPase cation transporting 13A2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ATPase cation transporting 13A2, transcript variant X3
cation-transporting ATPase 13A2 isoform X1
cation-transporting ATPase 13A2 isoform X2
cation-transporting ATPase 13A2 isoform X3
ATPase cation transporting 13A2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cation-transporting ATPase 13A2 isoform X5
succinate dehydrogenase complex, subunit B, iron sulfur (Ip), transcript variant X2
succinate dehydrogenase complex, subunit B, iron sulfur (Ip), transcript variant X1
succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial isoform X2
succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 30
UTP3 small subunit processome component, transcript variant X1
something about silencing protein 10 isoform X1
UTP3 small subunit processome component, transcript variant X2
something about silencing protein 10 isoform X2
zinc finger, MYND-type containing 12, transcript variant X2
zinc finger, MYND-type containing 12, transcript variant X1
zinc finger MYND domain-containing protein 12 isoform X2
zinc finger MYND domain-containing protein 12 isoform X1
ribosomal modification protein rimK-like family member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
EF-hand domain family, member D2, transcript variant X2
EF-hand domain family, member D2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
forkhead-associated (FHA) phosphopeptide binding domain 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
forkhead-associated domain-containing protein 1
testis-specific serine/threonine-protein kinase 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
PR domain containing 2, with ZNF domain a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine-rich repeat-containing protein 38-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cilia and flagella associated protein 107
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
short-chain dehydrogenase/reductase 3-like, transcript variant X1
short-chain dehydrogenase/reductase 3-like isoform X1
short-chain dehydrogenase/reductase 3-like, transcript variant X2
short-chain dehydrogenase/reductase 3-like isoform X2
vacuolar protein sorting 13 homolog D, transcript variant X7
vacuolar protein sorting 13 homolog D, transcript variant X2
vacuolar protein sorting 13 homolog D, transcript variant X4
vacuolar protein sorting 13 homolog D, transcript variant X5
vacuolar protein sorting 13 homolog D, transcript variant X3
vacuolar protein sorting 13 homolog D, transcript variant X1
intermembrane lipid transfer protein VPS13D isoform X7
intermembrane lipid transfer protein VPS13D isoform X2
intermembrane lipid transfer protein VPS13D isoform X4
intermembrane lipid transfer protein VPS13D isoform X5
intermembrane lipid transfer protein VPS13D isoform X3
intermembrane lipid transfer protein VPS13D isoform X1
vacuolar protein sorting 13 homolog D, transcript variant X6
intermembrane lipid transfer protein VPS13D isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
immunoglobin superfamily, member 21a, transcript variant X1
immunoglobin superfamily, member 21a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
immunoglobin superfamily, member 21a, transcript variant X3
immunoglobulin superfamily member 21a isoform X1
immunoglobulin superfamily member 21a isoform X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
rho guanine nucleotide exchange factor 10-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
rho guanine nucleotide exchange factor 10-like protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rho guanine nucleotide exchange factor 10-like protein, transcript variant X4
rho guanine nucleotide exchange factor 10-like protein, transcript variant X6
rho guanine nucleotide exchange factor 10-like protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
rho guanine nucleotide exchange factor 10-like protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho guanine nucleotide exchange factor 10-like protein, transcript variant X8
rho guanine nucleotide exchange factor 10-like protein, transcript variant X7
rho guanine nucleotide exchange factor 10-like protein isoform X8
rho guanine nucleotide exchange factor 10-like protein isoform X5
rho guanine nucleotide exchange factor 10-like protein isoform X4
rho guanine nucleotide exchange factor 10-like protein isoform X6
rho guanine nucleotide exchange factor 10-like protein isoform X2
rho guanine nucleotide exchange factor 10-like protein isoform X3
rho guanine nucleotide exchange factor 10-like protein isoform X1
rho guanine nucleotide exchange factor 10-like protein isoform X7
regulator of chromosome condensation 2, transcript variant X2
regulator of chromosome condensation 2, transcript variant X3
regulator of chromosome condensation 2, transcript variant X4
regulator of chromosome condensation 2, transcript variant X1
regulator of chromosome condensation 2, transcript variant X5
regulator of chromosome condensation 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
chymotrypsin-like elastase family member 2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like, transcript variant X8
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like, transcript variant X5
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like, transcript variant X6
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like, transcript variant X7
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like isoform X3
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like isoform X1
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like isoform X6
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like isoform X2
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like isoform X4
N-acetyllactosaminide alpha-1,3-galactosyltransferase-like isoform X5
zinc finger protein 362-like, transcript variant X2
zinc finger protein 362-like, transcript variant X1
tripartite motif containing 62, tandem duplicate 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
wingless-type MMTV integration site family, member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 127 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
wingless-type MMTV integration site family, member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cell division cycle 42, transcript variant X1
cell division control protein 42 homolog isoform X1
cell division cycle 42, transcript variant X2
cell division control protein 42 homolog isoform X2
adaptor related protein complex 5 subunit beta 1, transcript variant X2
adaptor related protein complex 5 subunit beta 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
adaptor related protein complex 5 subunit beta 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
chromosome 31 C1orf50 homolog, transcript variant X2
chromosome 31 C1orf50 homolog, transcript variant X1
uncharacterized protein C1orf50 homolog isoform X2
uncharacterized protein C1orf50 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
CTD nuclear envelope phosphatase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
CTD nuclear envelope phosphatase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
CTD nuclear envelope phosphatase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CTD nuclear envelope phosphatase 1-like isoform X3
CTD nuclear envelope phosphatase 1-like isoform X1
CTD nuclear envelope phosphatase 1A-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
F-box only protein 6-like, transcript variant X7
F-box only protein 6-like, transcript variant X9
F-box only protein 6-like, transcript variant X5
F-box only protein 6-like, transcript variant X3
F-box only protein 6-like, transcript variant X8
F-box only protein 6-like, transcript variant X10
F-box only protein 6-like, transcript variant X11
F-box only protein 6-like, transcript variant X4
F-box only protein 6-like, transcript variant X2
F-box only protein 6-like, transcript variant X1
F-box only protein 6-like, transcript variant X6
F-box only protein 2-like, transcript variant X3
F-box only protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
F-box only protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dispatched RND transporter family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dispatched RND transporter family member 3, transcript variant X2
dispatched RND transporter family member 3, transcript variant X3
UbiA prenyltransferase domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ubiA prenyltransferase domain-containing protein 1
mechanistic target of rapamycin kinase, transcript variant X1
mechanistic target of rapamycin kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
mechanistic target of rapamycin kinase, transcript variant X4
mechanistic target of rapamycin kinase, transcript variant X3
serine/threonine-protein kinase mTOR isoform X1
serine/threonine-protein kinase mTOR isoform X2
serine/threonine-protein kinase mTOR isoform X3
mannan-binding lectin serine protease 1-like
adherens junctions associated protein 1, transcript variant X4
adherens junctions associated protein 1, transcript variant X1
adherens junctions associated protein 1, transcript variant X5
adherens junctions associated protein 1, transcript variant X3
adherens junctions associated protein 1, transcript variant X2
adherens junction-associated protein 1 isoform X4
adherens junction-associated protein 1 isoform X1
adherens junction-associated protein 1 isoform X2
adherens junction-associated protein 1 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
nephronophthisis 4, transcript variant X2
nephronophthisis 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
DNA fragmentation factor, beta polypeptide (caspase-activated DNase)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
centrosomal protein 104, transcript variant X1
centrosomal protein 104, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
centrosomal protein 104, transcript variant X11
centrosomal protein 104, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
centrosomal protein 104, transcript variant X8
centrosomal protein 104, transcript variant X10
centrosomal protein 104, transcript variant X4
centrosomal protein 104, transcript variant X3
centrosomal protein 104, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
centrosomal protein 104, transcript variant X7
centrosomal protein 104, transcript variant X6
centrosomal protein of 104 kDa isoform X1
centrosomal protein of 104 kDa isoform X3
centrosomal protein of 104 kDa isoform X4
centrosomal protein of 104 kDa isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF01233
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7, like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
heterochromatin protein 1, binding protein 3, transcript variant X2
heterochromatin protein 1, binding protein 3, transcript variant X1
heterochromatin protein 1, binding protein 3, transcript variant X3
heterochromatin protein 1-binding protein 3
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X1
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X14
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X8
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X5
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X3
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X10
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X12
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X9
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X11
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X7
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X6
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X2
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X4
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X13
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X16
eukaryotic translation initiation factor 4 gamma 3-like, transcript variant X15
eukaryotic translation initiation factor 4 gamma 3-like isoform X14
eukaryotic translation initiation factor 4 gamma 3-like isoform X8
eukaryotic translation initiation factor 4 gamma 3-like isoform X5
eukaryotic translation initiation factor 4 gamma 3-like isoform X3
eukaryotic translation initiation factor 4 gamma 3-like isoform X10
eukaryotic translation initiation factor 4 gamma 3-like isoform X12
eukaryotic translation initiation factor 4 gamma 3-like isoform X9
eukaryotic translation initiation factor 4 gamma 3-like isoform X11
eukaryotic translation initiation factor 4 gamma 3-like isoform X7
eukaryotic translation initiation factor 4 gamma 3-like isoform X6
eukaryotic translation initiation factor 4 gamma 3-like isoform X1
eukaryotic translation initiation factor 4 gamma 3-like isoform X2
eukaryotic translation initiation factor 4 gamma 3-like isoform X4
eukaryotic translation initiation factor 4 gamma 3-like isoform X13
eukaryotic translation initiation factor 4 gamma 3-like isoform X15
eukaryotic translation initiation factor 4 gamma 3-like isoform X16
endothelin converting enzyme 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
endothelin converting enzyme 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
endothelin converting enzyme 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
endothelin converting enzyme 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
endothelin converting enzyme 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
endothelin converting enzyme 1, transcript variant X4
endothelin converting enzyme 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
endothelin converting enzyme 1, transcript variant X2
endothelin-converting enzyme 1 isoform X3
endothelin-converting enzyme 1 isoform X1
endothelin-converting enzyme 1 isoform X7
endothelin-converting enzyme 1 isoform X5
endothelin-converting enzyme 1 isoform X4
endothelin-converting enzyme 1 isoform X2
endothelin-converting enzyme 1 isoform X6
alkaline phosphatase, biomineralization associated, transcript variant X1
alkaline phosphatase, biomineralization associated, transcript variant X3
alkaline phosphatase, tissue-nonspecific isozyme isoform X1
alkaline phosphatase, tissue-nonspecific isozyme isoform X3
alkaline phosphatase, biomineralization associated, transcript variant X4
alkaline phosphatase, biomineralization associated, transcript variant X2
alkaline phosphatase, tissue-nonspecific isozyme isoform X2
alkaline phosphatase, tissue-nonspecific isozyme isoform X4
alkaline phosphatase, biomineralization associated, transcript variant X5
alkaline phosphatase, biomineralization associated, transcript variant X6
alkaline phosphatase, tissue-nonspecific isozyme isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
heparan sulfate proteoglycan 2, transcript variant X1
heparan sulfate proteoglycan 2, transcript variant X3
heparan sulfate proteoglycan 2, transcript variant X2
heparan sulfate proteoglycan 2, transcript variant X6
heparan sulfate proteoglycan 2, transcript variant X4
heparan sulfate proteoglycan 2, transcript variant X7
heparan sulfate proteoglycan 2, transcript variant X5
basement membrane-specific heparan sulfate proteoglycan core protein isoform X1
basement membrane-specific heparan sulfate proteoglycan core protein isoform X3
basement membrane-specific heparan sulfate proteoglycan core protein isoform X2
basement membrane-specific heparan sulfate proteoglycan core protein isoform X6
basement membrane-specific heparan sulfate proteoglycan core protein isoform X4
basement membrane-specific heparan sulfate proteoglycan core protein isoform X7
basement membrane-specific heparan sulfate proteoglycan core protein isoform X5
low density lipoprotein receptor class A domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
low-density lipoprotein receptor class A domain-containing protein 2
ubiquitin specific peptidase 48, transcript variant X1
ubiquitin specific peptidase 48, transcript variant X2
ubiquitin specific peptidase 48, transcript variant X3
ubiquitin specific peptidase 48, transcript variant X5
ubiquitin specific peptidase 48, transcript variant X4
ubiquitin specific peptidase 48, transcript variant X6
ubiquitin specific peptidase 48, transcript variant X7
ubiquitin carboxyl-terminal hydrolase 48 isoform X1
ubiquitin carboxyl-terminal hydrolase 48 isoform X2
ubiquitin carboxyl-terminal hydrolase 48 isoform X3
ubiquitin carboxyl-terminal hydrolase 48 isoform X4
ubiquitin carboxyl-terminal hydrolase 48 isoform X5
tyrosine-protein kinase STYK1, transcript variant X1
tyrosine-protein kinase STYK1, transcript variant X2
tyrosine-protein kinase STYK1 isoform X1
tyrosine-protein kinase STYK1, transcript variant X3
tyrosine-protein kinase STYK1 isoform X2
transmembrane protein 269, transcript variant X4
transmembrane protein 269, transcript variant X2
transmembrane protein 269, transcript variant X3
transmembrane protein 269, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain containing 40
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain-containing protein 40
uncharacterized si:dkey-205h13.2, transcript variant X2
uncharacterized si:dkey-205h13.2, transcript variant X1
uncharacterized si:dkey-205h13.2, transcript variant X3
uncharacterized protein si:dkey-205h13.2
complement C1q subcomponent subunit A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
complement C1q subcomponent subunit A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
complement C1q subcomponent subunit A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
complement C1q subcomponent subunit A-like isoform X1
complement C1q subcomponent subunit A-like isoform X2
complement C1q subcomponent subunit B-like
complement C1q subcomponent subunit C-like, transcript variant X1
complement C1q subcomponent subunit C-like, transcript variant X2
complement C1q subcomponent subunit C-like
ephrin type-B receptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ephrin type-B receptor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns